English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/86570
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Cannabinoid system in neurodegeneration: New perspectives in Alzheimer's disease

AuthorsCampillo, Nuria E. CSIC ORCID ; Páez, Juan A. CSIC ORCID
Issue Date2009
PublisherBentham Science Publishers
CitationMini reviews in medicinal chemistry 9: 539- 559 (2009)
AbstractAlzheimer's disease is a chronic and progressive neurodegenerative disorder. The presence of functional cannabinoid CB2 receptors in central nervous system (CNS) has provoked that this receptor and its agonist ligands are now considered as promising pharmacological targets for neurological diseases. Herein, we review the evidences supporting the potential role of the ECS as a therapeutic target, focused on CB2 receptor and its ligands, for the treatment of Alzheimer's disease. © 2009 Bentham Science Publishers Ltd.
Identifiersdoi: 10.2174/138955709788167628
issn: 1389-5575
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.